Tonix (TNXP) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Raymond James | Initiated Coverage | Strong Buy | $26.00 | Jun 25, 2026 |
| TD Cowen | Initiated Coverage | Buy | $22.00 | May 4, 2026 |
| Noble Capital Markets | Maintained | Outperform | $70.00 | Mar 20, 2025 |
| Alliance Global Partners | Maintained | Buy | $11.00 from $6.00 | Jul 22, 2024 |
| Dawson James | Initiated Coverage | Buy | $3.00 | Feb 28, 2024 |
| Alliance Global Partners | Maintained | Buy | $8.00 from $18.00 | Aug 1, 2023 |
| Alliance Global Partners | Maintained | Buy | $18.00 from $6.50 | Jun 2, 2023 |
Frequently asked questions
Is TNXP a buy, sell, or hold?
Analysts covering Tonix currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TNXP?
On Jun 25, 2026, Raymond James initiated coverage of Tonix at Strong Buy with a price target of $26.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.